Introduction
Methods
Population
Assessment of heart failure
Assessment of stroke
Possible confounders
Statistical analysis
Results
Characteristic | Median (interquartile range) or number (percentage) |
---|---|
Age (years) | 69.0 (62.3–76.7) |
Female sex | 4,596 (60.9%) |
Ever smoking | 4,649 (61.6%) |
Diabetes mellitus | 756 (10.0%) |
Body mass index (kg/m²) | 26.3 (24.1–28.0) |
Systolic blood pressure (mmHg) | 139 (125–152) |
Ankle brachial index | 1.05 (1.00–1.18) |
Antihypertensive drug use | 2,466 (32.7%) |
ACE-inhibitor use | 466 (6.2%) |
Antithrombotic drug use | 369 (4.9%) |
Heart failure (at baseline) | 233 (3.1%) |
Hazard ratio (95% CI) | ||||
---|---|---|---|---|
All stroke | Ischemic stroke | Hemorrhagic stroke | ||
Presence of heart failure | (n = 827) | (n = 470) | (n = 75) | |
No heart failure (N = 6,299) | 1 (reference) | 1 (reference) | 1 (reference) | |
Heart failure (N = 1,247) | Model A | 1.41 (1.15–1.72) | 1.51 (1.15–1.98) | 1.02 (0.49–2.16) |
Model B | 1.07 (0.86–1.32) | 1.02 (0.77–1.37) | 0.80 (0.37–1.76) |
Outcome | Presence of heart failure | Hazard ratio (95% CI) | |||
---|---|---|---|---|---|
0–30 days | 30 days–6 months | 6 months–5 years | |||
All stroke | No heart failure (N = 6299, 749 strokes) | 1 (reference) | 1 (reference) | 1 (reference) | |
Heart failure (N = 1247, 78 strokes)* | Model A | 4.27 (1.90–9.60) | 1.94 (1.14–3.31) | 0.99 (0.74–1.33) | |
Model B | 3.59 (1.59–8.10) | 1.60 (0.93–2.73) | 0.78 (0.58–1.05) | ||
Ischemic stroke | No heart failure (N = 6299, 428 ischemic strokes) | 1 (reference) | 1 (reference) | 1 (reference) | |
Heart failure (N = 1247, 42 ischemic strokes)* | Model A | 5.79 (2.15-15.62) | 3.50 (1.96-6.25) | 0.83 (0.53-1.29) | |
Model B | 4.60 (1.70-12.49) | 2.75 (1.53-4.94) | 0.58 (0.37-0.92) |